1
/
of
0
FDA Drug Approval, A208040, DABIGATRAN ETEXILATE MESYLATE
FDA Drug Approval, A208040, DABIGATRAN ETEXILATE MESYLATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 208040
Company: ALKEM LABS LTD
Drug Name: DABIGATRAN ETEXILATE MESYLATE
Active Ingredients: DABIGATRAN ETEXILATE MESYLATE
Strength: EQ 150MG BASE
Dosage Form/Route: CAPSULE;ORAL
Action Date: 03/11/2020
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: ALKEM LABS LTD
Drug Name: DABIGATRAN ETEXILATE MESYLATE
Active Ingredients: DABIGATRAN ETEXILATE MESYLATE
Strength: EQ 150MG BASE
Dosage Form/Route: CAPSULE;ORAL
Action Date: 03/11/2020
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Couldn't load pickup availability